Skip to main content

FDA recall, , Moderate risk

American Regent Cyanocobalamin Injection

Cyanocobalamin Injection contains particulate matter identified as glass.

What happened

American Regent, Inc., of Shirley, New York, voluntarily recalled Cyanocobalamin Injection, USP, 1000 mcg/mL, 25 x 1 mL multi-dose vials, Rx only, because the product contains particulate matter identified as glass. The recall began on October 14, 2026, and was added to the FDA's Enforcement Report on October 27, 2026.

The product is distributed nationwide within the United States. Customers were notified by letter.

What to do

The FDA notice gives no instructions for this recall. FDA's general advice for medicine recalls:

  1. Check the FDA or company notice for instructions specific to this product.
  2. Ask your pharmacist or doctor whether your lot is affected and what to do.

Is yours affected?

Match the NDC and lot code listed under your product.

An NDC (National Drug Code) is usually printed on the drug's label.

  1. NDC
    • 0517-0031-25
    • 0517-0031-01
    Lot code
    • 24394

Recall details

Posted by FDA
Recall began
Status
Open
Sold in

Nationwide within the United States

Recalled by
American Regent, Inc.Shirley, New York
Risk

Moderate risk

Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

FDA event number
100143
Recall number
D-0172-2027
Recall type
Voluntary: Firm initiated
How the company first told customers
Letter

All recalls from American Regent, Inc.

Timeline

FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.

  1. American Regent began the recall

  2. FDA posted the recall to its Enforcement Report

  3. Added to Recall Canary

  4. FDA rated the recall Class II (moderate risk)

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Nov 5, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)